Human SDF-1/CXCL12(Stromal Cell Derived Factor 1) ELISA Kit
中文名称：人基质细胞衍生因子1(SDF-1/CXCL12)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 0.16-10 ng/mL
- 灵敏度： 0.1 ng/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人SDF-1/CXCL12抗体包被于酶标板上，实验时样品（或标准品）中的人SDF-1/CXCL12会与包被抗体结合。后依次加入生物素化的抗人SDF-1/CXCL12抗体和辣根过氧化物酶标记的亲和素，抗人SDF-1/CXCL12抗体与结合在包被抗体上的人SDF-1/CXCL12结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，SDF-1/CXCL12浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中SDF-1/CXCL12的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 0.16-10 ng/mL |
| 灵敏度 | 0.1 ng/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人SDF-1/CXCL12，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
A tetrahedral DNA nanostructure-mediated miRNA inhibitor delivery system: Type H vessel-related bone healing during distraction osteogenesis
IF: 13.300 -
The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment
IF: 4.800 -
A Targeted Proteomics Approach Reveals a Serum Protein Signature as a Diagnostic Biomarker for Colorectal Cancer
IF: 4.200Journal： Journal of Inflammation Research (2024)Reactivity：HumanSample Type：peripheral blood -
Sulforaphane inhibits the migration and invasion of BPDE-induced lung adenocarcinoma cells by regulating NLRP12
IF: 3.800 -
PSO/SDF-1 composite hydrogel promotes osteogenic differentiation of PDLSCs and bone regeneration in periodontitis rats
IF: 3.400 -
Pleural Mesothelial Cells-Induced Monocytes to the Pleural Cavity through the Effect of C3 Lytic Products in Tuberculous Pleural Effusion
IF: 2.600Journal： INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2024)Reactivity：HumanSample Type：pleural fluids,plasma -
CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective
IF: 0.600Journal： Turkish Journal of Biochemistry-Turk Biyokimya Dergisi (2024)Reactivity：HumanSample Type：serum -
CREB1-driven CXCR4hi neutrophils promote skin inflammation in mouse models and human patients
IF: 16.600 -
Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
IF: 11.300 -
Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C–X–C motif chemokine ligand 12 from cancer associated fibroblasts
IF: 7.400
实验操作视频
